Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-041135
Filing Date
2021-06-16
Accepted
2021-06-16 20:02:37
Documents
1
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4093
  Complete submission text file 0001209191-21-041135.txt   5711
Mailing Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037
Business Address 10975 N. TORREY PINES RD., #150 LA JOLLA CA 92037 858-401-7900
Avidity Biosciences, Inc. (Issuer) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KEZAR LIFE SCIENCES, INC. 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Henig Noreen (Reporting) CIK: 0001810995 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39321 | Film No.: 211022982